News from

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2790 Results
Delivering a one-two punch to superbugs to fight infections
Rakesh Krishnan sits at a computer staring at a 3D rendering of a protein.

Researchers led by César de la Fuente of the Perelman School of Medicine have created new peptides that fight hard-to-treat “superbug” infections by punching holes in bacterial cells and stimulating immune cells to signal for more defenders.

(Image: Courtesy of Jianing Bai) 

Delivering a one-two punch to superbugs to fight infections

Penn researchers create mirror-image molecules that both kill pathogens outright and rally the immune system—an advance aimed at the growing crisis of antimicrobial resistance.

3 min. read

Neurobowl reimagines how the next generation of neurologists is trained
Sashank Prasad and Raymond Price.

Sashank Prasad (left), chief of Neurology at Penn Presbyterian Medical Center, and Raymond Price, chief of Neurology at Pennsylvania Hospital.

(Image: Courtesy of Penn Medicine News)

Neurobowl reimagines how the next generation of neurologists is trained

Sashank Prasad and Raymond Price have collaborated for years on an online quiz-show to teach uncommon neurological conditions for Penn Medicine students, and have introduced the program to other institutions as well.

From Penn Medicine News

2 min. read

AI x Science Postdoctoral Fellowship
Aerial shot of Amy Guttman Hall

Bhuvnesh Jain of the School of Arts & Sciences has teamed up with PIK University Professor René Vidal of the Perelman School of Medicine and the School of Engineering and Applied Science to create the AI x Science Fellowship offering postdoctoral researchers across the University opportunities to collaborate across disciplines.

nocred

AI x Science Postdoctoral Fellowship

Bhuvnesh Jain and René Vidal have teamed up to create the AI x Science Fellowship, which builds on the thriving postdoctoral program of the Data Driven Discovery Initiative to foster cross-disciplinary collaboration among researchers across the University.

6 min. read

Livesaving personalized CRISPR editing therapy
Kiran Musunuru and Rebecca Ahrens-Nicklas holding KJ in the hospital.

Penn Medicine’s Kiran Musunuru and Rebecca Ahrens-Nicklas holding KJ post infusion.

(Image: Courtesy of Children’s Hospital of Philadelphia)

Livesaving personalized CRISPR editing therapy

A landmark study from CHOP and Penn Medicine showcases the power of customized gene editing therapy to treat a patient with a rare metabolic disease

Matt Toal

5 min. read

A mothers’ meetup like no other for families formed through uterus transplant
Two people embrace at a uterine transplant meetup lunch with a baby in a stroller and gifts on a conference table.

Image: Courtesy of Penn Medicine News

A mothers’ meetup like no other for families formed through uterus transplant

One week before Mother’s Day, those who gave birth through uterus transplant gathered for a special brunch with those who donated their uteruses for the procedure, and their respective families.

Alex Gardner

2 min. read

Soon-to-be-graduate hopes to deliver primary care to rural communities
Chip Chambers stands on college campus.

nocred

Soon-to-be-graduate hopes to deliver primary care to rural communities

Fueled by his faith, Chip Chambers, a fifth-year M.D./M.B.A. student in the Perelman School of Medicine and Wharton School, has always looked for ways to serve.“My faith is a huge motivator of everything that I do. I just believe that I’ve been blessed with a lot of things that I didn’t earn and that I have a responsibility to steward those for the good of other people and not for myself,” Chambers says.

4 min. read

Enhanced CAR T cell therapy offers new strategy for lymphoma
3-D rendering of chimeric antigen receptor T (CAR-T) cell therapy, a treatment for a variety of cancers

Image: iStock/Naeblys

Enhanced CAR T cell therapy offers new strategy for lymphoma

A new study from Penn Medicine marks a significant development in the ongoing evolution of CAR T cell therapy, as a novel cytokine-enhanced CAR T that has been tested in patients with blood cancer shows robust response rates.

2 min. read